Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroblastoma in 1987 (1)].

T Philip1, B Kremens, J P Chappuis

  • 1Centre Léon-Bérard, Service de Pédiatrie, Lyon, France.

Pediatrie
|January 1, 1987
PubMed
Summary

Neuroblastoma, a common childhood cancer in those under five, presents unique clinical and biological characteristics. Recent advancements offer hope for improved outcomes in disseminated forms, previously fatal.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.

Leukemia·2017
Same author

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia.

Leukemia·2017
Same author

Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004.

Klinische Padiatrie·2015
Same author

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia.

Klinische Padiatrie·2015
Same author

Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival.

Leukemia·2015

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Tumor Immunology

Context:

  • Neuroblastoma is a rare but frequent pediatric cancer, primarily affecting children under five.
  • Distinct clinical presentations in infants (<1 year) show better prognosis than disseminated forms in older children.
  • Historically, disseminated neuroblastoma in children over one year had a poor prognosis.

Purpose:

  • To highlight neuroblastoma as a model for studying pediatric oncology challenges and advancements.
  • To explore its utility in understanding spontaneous tumor maturation and immune system interactions.
  • To examine the role of genetics and novel therapeutic techniques in cancer treatment.

Summary:

  • Neuroblastoma serves as a crucial model for understanding childhood malignancies, particularly in its varied clinical and biological aspects.
  • The study emphasizes the need for interdisciplinary approaches in pediatric oncology, showcasing recent progress.
  • It explores neuroblastoma's potential for studying tumor maturation, immune surveillance, genetic influences, and future therapeutic strategies.

Impact:

  • Provides insights into the complexities of childhood cancer, offering a framework for research and treatment development.
  • Underscores the importance of early detection, interdisciplinary care, and innovative therapies for improving pediatric cancer outcomes.
  • Highlights the potential for neuroblastoma research to influence future cancer therapy and screening strategies.

Related Experiment Videos